Stock listing

NASDAQ:ESLA Estrella Immunopharma, Inc. Stock

Home listing (NASDAQ) of Estrella Immunopharma, Inc.

Follow Estrella Immunopharma, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ESLA

$0.321 USD -0.012 (-3.6%)

Close on Nov 20, 2026

Past year -80.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.321 – $0.400 USDNov 20, 2026
Volume
251,677 sharesNov 20, 2026
Market cap
$14.11M USDAt the close on Nov 20, 2026 · price × 43.97M shares outstanding
52-week range
$0.240 – $2.270 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.09M USDMedian day 71,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Estrella Immunopharma, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ESLA · Home$0.321 USD-0.012 (-3.6%)251,677$0.360$0.400$0.321$0.333Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ESLA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.321-0.012-3.6%$0.360$0.400$0.321251,677
$0.333+0.001+0.4%$0.335$0.380$0.330446,508
$0.332-0.048-12.7%$0.440$0.470$0.300747,761
$0.380-0.134-26.1%$0.499$0.525$0.380532,000
$0.514-0.005-1.0%$0.521$0.552$0.464222,000
$0.519-0.275-34.6%$0.799$0.799$0.4001,585,900
$0.794+0.047+6.3%$0.775$0.851$0.731782,800
$0.747+0.233+45.3%$0.530$0.770$0.5303,951,900
$0.514+0.139+37.1%$0.430$0.599$0.4306,584,500
$0.375-0.035-8.5%$0.400$0.445$0.372140,400
$0.410-0.034-7.7%$0.444$0.444$0.400162,800
$0.444+0.026+6.2%$0.438$0.480$0.403128,700
$0.418-0.008-1.9%$0.429$0.475$0.352526,300
$0.426-0.213-33.3%$0.639$0.639$0.425617,000
$0.639-0.090-12.3%$0.720$0.787$0.624165,700
$0.729-0.093-11.3%$0.812$0.825$0.701270,200
$0.822-0.110-11.8%$0.918$0.990$0.751495,600
$0.932+0.013+1.4%$0.880$0.950$0.846609,700
$0.919-0.066-6.7%$1.050$1.150$0.8802,579,400
$0.985+0.258+35.5%$0.764$0.999$0.7413,718,700
$0.727+0.177+32.2%$0.562$0.759$0.5556,851,000
$0.550+0.150+37.5%$0.419$0.591$0.3887,019,400
$0.400+0.020+5.3%$0.349$0.419$0.334193,900
$0.380-0.050-11.6%$0.369$0.424$0.2401,695,900
$0.430-0.105-19.6%$0.495$0.510$0.4214,239,600
$0.535+0.217+68.2%$0.310$0.850$0.30263,107,500
$0.318+0.004+1.3%$0.310$0.330$0.300198,900
$0.314-0.015-4.6%$0.330$0.342$0.295319,000
$0.329-0.081-19.8%$0.325$0.363$0.320900,000
$0.410-0.008-1.9%$0.352$0.443$0.30819,847,400
$0.418-0.001-0.2%$0.410$0.426$0.36171,100
$0.419-0.010-2.3%$0.412$0.443$0.41248,900
$0.429-0.011-2.5%$0.442$0.461$0.41168,700
$0.440-0.028-6.0%$0.460$0.460$0.44031,100
$0.468-0.007-1.5%$0.461$0.506$0.46014,500
$0.475+0.008+1.7%$0.460$0.480$0.46014,400
$0.467+0.007+1.5%$0.499$0.499$0.46318,400
$0.460+0.029+6.7%$0.470$0.490$0.44026,100
$0.431-0.050-10.4%$0.467$0.500$0.43136,000
$0.481+0.010+2.1%$0.471$0.500$0.46727,800
$0.471-0.001-0.2%$0.470$0.500$0.4689,200
$0.472-0.013-2.7%$0.475$0.500$0.46132,300
$0.485-0.017-3.4%$0.550$0.560$0.48062,600
$0.502-0.027-5.1%$0.531$0.580$0.50052,000
$0.529+0.003+0.6%$0.569$0.579$0.50956,900
$0.526-0.114-17.8%$0.650$0.650$0.510149,900
$0.640+0.029+4.7%$0.650$0.650$0.58645,200
$0.611-0.025-3.9%$0.680$0.680$0.59448,100
$0.636-0.024-3.6%$0.730$0.730$0.62327,400
$0.660-0.013-1.9%$0.696$0.720$0.66025,900
$0.673+0.035+5.5%$0.620$0.740$0.62082,000
$0.638-0.002-0.3%$0.610$0.685$0.61028,600
$0.640-0.006-0.9%$0.622$0.720$0.62053,300
$0.646+0.005+0.8%$0.725$0.738$0.58569,400
$0.641-0.049-7.1%$0.719$0.744$0.64017,300
$0.690-0.002-0.3%$0.703$0.725$0.69017,400
$0.692-0.033-4.6%$0.720$0.725$0.6924,900
$0.725+0.020+2.8%$0.680$0.730$0.66013,100
$0.705-0.017-2.4%$0.755$0.755$0.62544,300
$0.722-0.008-1.1%$0.740$0.750$0.70741,800
$0.730-0.003-0.4%$0.750$0.750$0.72511,900
$0.733-0.002-0.3%$0.759$0.770$0.72038,300
$0.7350.0000.0%$0.757$0.764$0.72020,300
$0.735-0.010-1.3%$0.761$0.761$0.7218,200
$0.745+0.008+1.1%$0.770$0.770$0.72029,700
Ticker
NASDAQ:ESLA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Estrella Immunopharma, Inc. news

Estrella Immunopharma, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 22 in all · newest Nov 16, 2026 · oldest 2024
Decks
2 decks · latest March 2026

Where Estrella Immunopharma, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ESLA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ESLABOATSUnited StatesUSD

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$14.01M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Negative equity
Beta vs S&P 500
1.31

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Estrella Immunopharma, Inc. · NASDAQ:ESLAUS$14.11MUS$14.01Mn/an/an/an/an/an/a1.31
Context Therapeutics Inc. · NASDAQ:CNTXUS$14.70M−US$19.50Mn/an/an/a0.5×n/a0.0×0.99
NewcelX Ltd. · NASDAQ:NCELUS$14.67MUS$14.35Mn/an/an/a2.4×n/a0.1×0.89
Hepion Pharmaceuticals, Inc. · OTC:HEPAUS$14.63MUS$10.37Mn/an/an/an/an/an/a-1.02
Vectorite Biomedical, Inc. · TPEX:4170US$14.21MUS$9.16M4.9×4.9×n/a0.9×156.6%0.0×n/a
Citius Pharmaceuticals, Inc. · NASDAQ:CTXRUS$13.96M−US$3.05Mn/an/an/a0.2×n/a0.0×1.71
TaiwanJ Pharmaceuticals Co., Ltd. · TPEX:6549US$13.68MUS$11.86Mn/an/an/a7.0×n/a0.0×n/a
Actuate Therapeutics, Inc. · NASDAQ:ACTUUS$13.60MUS$11.50Mn/an/an/an/an/an/a1.75
BeyondSpring, Inc. · NASDAQ:BYSIUS$13.57MUS$12.99M0.3×n/an/a0.9×n/a0.0×1.31
Acumen Pharmaceuticals, Inc. · NASDAQ:ABOSUS$13.49M−US$38.84Mn/an/an/a0.4×n/a0.8×1.45
Pharma Equity Group A/S Class A · OMXCOP:PEGUS$13.47MUS$15.05Mn/an/a52.8×3.6×n/a0.4×n/a
Median of the othersUS$13.82MUS$10.94M2.6×4.9×52.8×0.9×156.6%0.0×1.31

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
12.00 USD · Analysts' mean
EPS, year to Dec 2026
-0.29 · 1 analyst

Team and board

Officers

OfficerRole
Cynthia PussinenChairperson of the Board
Jiandong XuChief Financial Officer
Cheng LiuChief Scientific Officer

Board

DirectorRole
Cynthia PussinenChairperson of the Board
Dengyao JiaDirector
Fan WuDirector
Hong ZhangDirector
Janelle WuDirector
Marsha RobertsDirector
Pei XuDirector

Events

QuarterResultsShare move
Q3 2026Nov 13, 2026−26.8%
Q2 2026Aug 13, 2026 · After close−0.3%
Q1 2026May 18, 2026 · Before open+0.9%
Q4 2025Mar 18, 2026 · Before open−2.7%
Q3 2025Nov 12, 2025 · After close+4.8%
Q2 2025Aug 12, 2025 · Before open0.0%
Q1 2025May 14, 2025 · After close−5.0%
Quarter to Dec 31, 2024Mar 25, 2025 · After close−2.0%
Q3 2024Nov 14, 2024+6.0%
Q4 2022Mar 14, 2023−2.1%
All 16 quarters
QuarterResultsShare move
Q3 2022Nov 14, 2022+0.3%
Q2 2022Aug 8, 20220.0%
Q1 2022May 16, 20220.0%
Q4 2021Mar 29, 20220.0%
Quarter to Sep 30, 2021Nov 10, 2021−0.4%
Quarter to Jun 30, 2021Jul 19, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (March 2026)Investor deck27 slidesMarch 2026
Investor Presentation (April 2024)Investor deck29 slidesApr 10, 2024

Open Decks

Financings

RaiseDate
Registered direct offering of common stock and pre-funded warrants with concurrent private placement common warrants
Closed: US$8M raised · US$1.58 a share · Warrants at US$1.39 for 60 months · Aegis Capital Corp.
Dealers: Aegis Capital Corp. (lead)
Use of proceeds: General corporate purposes and working capital
Jan 6, 2026
Private placement of shares of common stock
Announced: about US$3.35M · US$1.5 a share
Use of proceeds: Complete Phase I of the STARLIGHT-1 trial of EB103 in adults with relapsed/refractory B-cell non-Hodgkin's lymphoma
Jun 3, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as TradeUP Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Jul 14, 2021.

Price
US$10.00 a unit
Units offered
4,000,000 units
Offering size
US$40 million
Underwriters' option
Up to 600,000 more units
Listing
UPTDU on the Nasdaq Capital Market
Underwriters
Tiger Brokers, EF HUTTON, R. F. Lafferty & Co., Inc. · In the order on the cover
Units delivered
On or about Jul 19, 2021

Steps

StepWhen
Filed publiclyFeb 19, 2021
Amended 9 timesNewest Jul 9, 2021
Shares registered with an exchangeJul 14, 2021
Declared effective by the SECJul 14, 2021
Final prospectus, with the priceJul 19, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jul 19, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Research and development10.2M4.11M10.5M
Operating income-13.1M-7.31M-11.1M-1.57M-249.1K
Income before tax-13.1M-7.31M-11.1M-915.5K-247.7K
Income tax8381.63K80.6K0
Net income-13.1M-7.31M-11.1M-996.1K-247.7K
Earnings per share, basic-0.35-0.27-36.35-0.70-0.17
Earnings per share, diluted-0.35-0.27-36.35

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents1.38M4.17M2.48M40.8K478.9K
Receivables273.1K
Current assets1.68M4.45M2.75M52.4K616.0K
Total assets3.18M4.45M3.03M9.72M45.8M
Current liabilities13.5M180.7K9.76M1.07M73.2K
Total liabilities13.5M180.7K9.77M2.65M1.62M
Shareholders' equity-10.4M4.27M-11.7M-6.48M-1.01M
Shares outstanding38.0M36.6M978.2K1.42M1.42M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-1.79M-16.1M-1.34M-1.04M-316.2K
Cash from investing4.96M-273.1K36.2M-45.2M
Cash from financing2.25M12.8M-35.6M46.0M
Change in cash467.4K1.69M-1.61M-438.1K478.9K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
3 · Initial statement of ownershipNov 3, 2026Insider tradeSEC
8-K · Current reportOct 29, 2026Management or board changeSEC
8-K · Current reportSep 8, 2026Current reportSEC
4 · Change in ownershipAug 26, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
8-K · Current reportAug 21, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportJun 30, 2026Meeting outcomeSEC
DEF 14A · Proxy statementMay 27, 2026Meeting noticeSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2026Explanation requestSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-K/A · Annual report, amendedApr 30, 2026Annual reportSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
10-K · Annual reportMar 17, 2026Annual reportSEC
424B3 · ProspectusFeb 13, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJan 26, 2026Other filingsSEC
CORRESP · Letter to the SECJan 22, 2026Other filingsSEC
S-1/A · Registration statement, amendedJan 21, 2026Offer documentSEC
S-1/A · Registration statement, amendedJan 16, 2026Offer documentSEC
8-K · Current reportJan 13, 2026Current reportSEC
8-K · Current reportJan 6, 2026Material contractSEC
424B5 · ProspectusJan 6, 2026Offer documentSEC
UPLOAD · Letter from the SECDec 29, 2025Other filingsSEC
S-1 · Registration statementDec 22, 2025Offer documentSEC
8-K · Current reportDec 4, 2025Current reportSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025Current reportSEC
3 · Initial statement of ownershipOct 1, 2025Insider tradeSEC
8-K · Current reportSep 29, 2025Current reportSEC
8-K · Current reportSep 26, 2025Management or board changeSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
8-K · Current reportAug 6, 2025Current reportSEC
8-K · Current reportJun 5, 2025Current reportSEC
8-K · Current reportJun 3, 2025Material contractSEC
8-K · Current reportMay 29, 2025Current reportSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportMay 2, 2025Current reportSEC
10-KT · Transition reportMar 25, 2025Annual reportSEC
8-K · Current reportFeb 21, 2025Current reportSEC
8-K · Current reportFeb 19, 2025Current reportSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
S-8 · Registration statement for employee plansDec 23, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 20, 2024Other filingsSEC
CORRESP · Letter to the SECDec 17, 2024Other filingsSEC
424B3 · ProspectusDec 17, 2024Offer documentSEC
UPLOAD · Letter from the SECDec 17, 2024Other filingsSEC
8-K · Current reportDec 16, 2024Current reportSEC
S-3 · Registration statementDec 12, 2024Offer documentSEC
424B3 · ProspectusDec 9, 2024Offer documentSEC
8-K · Current reportDec 6, 2024Material contractSEC
424B3 · ProspectusNov 27, 2024Offer documentSEC
8-K · Current reportNov 26, 2024Current reportSEC
8-K · Current reportNov 25, 2024Current reportSEC
424B3 · ProspectusNov 18, 2024Offer documentSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K/A · Current report, amendedNov 7, 2024Material contractSEC
8-K · Current reportNov 7, 2024Management or board changeSEC
10-K/A · Annual report, amendedOct 28, 2024Annual reportSEC
424B3 · ProspectusOct 2, 2024Offer documentSEC
10-K · Annual reportSep 26, 2024Annual reportSEC
3 · Initial statement of ownershipAug 23, 2024Insider tradeSEC
424B3 · ProspectusAug 21, 2024Offer documentSEC
8-K · Current reportAug 20, 2024Management or board changeSEC
424B3 · ProspectusAug 6, 2024Offer documentSEC
8-K · Current reportAug 5, 2024Current reportSEC
424B3 · ProspectusJul 2, 2024Offer documentSEC
8-K · Current reportJul 1, 2024Current reportSEC
424B3 · ProspectusMay 15, 2024Offer documentSEC
10-Q · Quarterly reportMay 14, 2024Quarterly reportSEC
8-K · Current reportMay 13, 2024Material contractSEC
8-K · Current reportApr 10, 2024Current reportSEC
424B3 · ProspectusMar 8, 2024Offer documentSEC
8-K · Current reportMar 8, 2024Current reportSEC
424B3 · ProspectusMar 7, 2024Offer documentSEC
8-K · Current reportMar 6, 2024Material contractSEC
424B3 · ProspectusFeb 15, 2024Offer documentSEC
10-Q · Quarterly reportFeb 14, 2024Quarterly reportSEC
424B3 · ProspectusFeb 12, 2024Offer documentSEC
8-K · Current reportFeb 2, 2024Current reportSEC
8-K · Current reportJan 30, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveDec 29, 2023Other filingsSEC
424B3 · ProspectusDec 28, 2023Offer documentSEC
CORRESP · Letter to the SECDec 27, 2023Other filingsSEC
CORRESP · Letter to the SECDec 15, 2023Other filingsSEC
S-1/A · Registration statement, amendedDec 15, 2023Offer documentSEC
UPLOAD · Letter from the SECNov 21, 2023Other filingsSEC
10-Q · Quarterly reportNov 20, 2023Quarterly reportSEC
NT 10-Q · Late filing noticeNov 14, 2023Explanation requestSEC
8-K/A · Current report, amendedNov 14, 2023Current reportSEC
CORRESP · Letter to the SECNov 13, 2023Other filingsSEC
S-1/A · Registration statement, amendedNov 13, 2023Offer documentSEC
SC 13D · Big-stake noticeOct 27, 2023Big-stake noticeSEC
UPLOAD · Letter from the SECOct 23, 2023Other filingsSEC
S-1 · Registration statementOct 10, 2023Offer documentSEC
3 · Initial statement of ownershipOct 10, 2023Insider tradeSEC
3 · Initial statement of ownershipOct 10, 2023Insider tradeSEC
3 · Initial statement of ownershipOct 10, 2023Insider tradeSEC
3 · Initial statement of ownershipOct 10, 2023Insider tradeSEC
3 · Initial statement of ownershipOct 10, 2023Insider tradeSEC
3 · Initial statement of ownershipOct 10, 2023Insider tradeSEC
3 · Initial statement of ownershipOct 10, 2023Insider tradeSEC
8-K · Current reportOct 5, 2023Acquisition or disposalSEC
4 · Change in ownershipOct 5, 2023Insider tradeSEC
25-NSEOct 5, 2023Other filingsSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
4 · Change in ownershipOct 2, 2023Insider tradeSEC
425Sep 20, 2023Other filingsSEC
8-K · Current reportSep 20, 2023Material contractSEC
425Sep 18, 2023Other filingsSEC
8-K · Current reportSep 18, 2023Material contractSEC
425Aug 18, 2023Other filingsSEC
8-K · Current reportAug 18, 2023Material contractSEC
10-Q · Quarterly reportJul 31, 2023Quarterly reportSEC
425Jul 31, 2023Other filingsSEC
8-K · Current reportJul 31, 2023Meeting outcomeSEC
DEFA14A · Additional proxy materialJul 26, 2023Meeting noticeSEC
425Jul 26, 2023Other filingsSEC
8-K · Current reportJul 26, 2023Material contractSEC
SEC STAFF LETTERJul 25, 2023Other filingsSEC
8-K · Current reportJul 21, 2023Material contractSEC
425Jul 19, 2023Other filingsSEC
8-K · Current reportJul 19, 2023Material contractSEC
8-K · Current reportJul 19, 2023Material contractSEC
DEFA14A · Additional proxy materialJul 12, 2023Meeting noticeSEC
8-K · Current reportJul 12, 2023Current reportSEC
EFFECT · Notice that a registration is effectiveJul 12, 2023Other filingsSEC
424B3 · ProspectusJul 11, 2023Offer documentSEC
S-4/A · Registration statement, amendedJul 7, 2023Offer documentSEC
CORRESP · Letter to the SECJul 6, 2023Other filingsSEC
S-4/A · Registration statement, amendedJul 6, 2023Offer documentSEC
CORRESP · Letter to the SECJun 30, 2023Other filingsSEC
S-4/A · Registration statement, amendedJun 30, 2023Offer documentSEC
UPLOAD · Letter from the SECJun 26, 2023Other filingsSEC
8-K · Current reportJun 23, 2023Current reportSEC
425Jun 20, 2023Other filingsSEC
8-K · Current reportJun 20, 2023Material contractSEC
UPLOAD · Letter from the SECJun 16, 2023Other filingsSEC
DEF 14A · Proxy statementJun 16, 2023Meeting noticeSEC
CORRESP · Letter to the SECJun 15, 2023Other filingsSEC
S-4/A · Registration statement, amendedJun 15, 2023Offer documentSEC
8-K · Current reportJun 9, 2023Material contractSEC
PRER14AJun 2, 2023Other filingsSEC
PRE 14A · Preliminary proxy statementMay 25, 2023Meeting noticeSEC
425May 19, 2023Other filingsSEC
8-K · Current reportMay 19, 2023Material contractSEC
10-Q · Quarterly reportMay 17, 2023Quarterly reportSEC
UPLOAD · Letter from the SECMay 17, 2023Other filingsSEC
NT 10-Q · Late filing noticeMay 15, 2023Explanation requestSEC
SEC STAFF LETTERMay 12, 2023Other filingsSEC
CORRESP · Letter to the SECMay 1, 2023Other filingsSEC
S-4/A · Registration statement, amendedMay 1, 2023Offer documentSEC
425Apr 26, 2023Other filingsSEC
8-K · Current reportApr 26, 2023Material contractSEC
425Apr 24, 2023Other filingsSEC
8-K · Current reportApr 24, 2023Material contractSEC
8-K · Current reportApr 21, 2023Current reportSEC
425Apr 13, 2023Other filingsSEC
8-K · Current reportApr 13, 2023Material contractSEC
8-K · Current reportApr 5, 2023Current reportSEC
425Mar 17, 2023Other filingsSEC
8-K · Current reportMar 17, 2023Material contractSEC
10-K · Annual reportMar 14, 2023Annual reportSEC
SC 13G/A · Big-stake notice, amendedMar 10, 2023Big-stake noticeSEC
425Mar 8, 2023Other filingsSEC
8-K · Current reportMar 3, 2023Material contractSEC
SEC STAFF LETTERFeb 22, 2023Other filingsSEC
425Feb 21, 2023Other filingsSEC
8-K · Current reportFeb 21, 2023Material contractSEC
UPLOAD · Letter from the SECFeb 17, 2023Other filingsSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
S-4/A · Registration statement, amendedFeb 2, 2023Offer documentSEC
SC 13G/A · Big-stake notice, amendedJan 31, 2023Big-stake noticeSEC
425Jan 24, 2023Other filingsSEC
8-K · Current reportJan 24, 2023Material contractSEC
3 · Initial statement of ownershipJan 9, 2023Insider tradeSEC
8-K · Current reportJan 5, 2023Material contractSEC
UPLOAD · Letter from the SECDec 29, 2022Other filingsSEC
8-K · Current reportDec 29, 2022Meeting outcomeSEC
S-4/A · Registration statement, amendedDec 16, 2022Offer documentSEC
CORRESP · Letter to the SECDec 16, 2022Other filingsSEC
UPLOAD · Letter from the SECDec 7, 2022Other filingsSEC
DEF 14A · Proxy statementDec 6, 2022Meeting noticeSEC
PRER14ADec 2, 2022Other filingsSEC
PRE 14A · Preliminary proxy statementNov 25, 2022Meeting noticeSEC
UPLOAD · Letter from the SECNov 14, 2022Other filingsSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
S-4 · Registration statementOct 17, 2022Offer documentSEC
8-K · Current reportOct 11, 2022Current reportSEC

This page holds 200 of 260 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Estrella Immunopharma, Inc.’s releases · as of Nov 11, 2026

Common shares
43,970,085
Fully diluted
43,970,085

Fully diluted

LineSharesAs of
Common shares43,970,085Nov 11, 2026

Warrants and options

Lot
Warrants · US$1.39 · expire about Jan 2031

Share count over time

CountShares
Nov 11, 202643,970,085

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Armistice Capital, LLC3.67M8.3%US$1.71M−305KNov 16, 2026
Vanguard511K1.2%US$239K+29,475Nov 13, 2026
Geode Capital141K0.32%US$65,868−183Nov 6, 2026
BlackRock52,8690.12%US$24,674+836Nov 13, 2026
State Street43,2520.10%US$20,186No changeNov 12, 2026
Northern Trust34,8610.08%US$16,270No changeNov 16, 2026
Citadel27,5550.06%US$12,860NewNov 16, 2026
Renaissance Technologies14,7000.03%US$6,860−24,400Nov 12, 2026
Tower Research Capital LLC (TRC)6,4990.01%US$3,033+3,191Nov 16, 2026
Citigroup Inc5,9100.01%US$2,758NewNov 4, 2026
All 15 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
UBS1,356<0.01%US$633−365Nov 10, 2026
TD1,089<0.01%US$509No changeNov 16, 2026
Wolverine Asset Management LLC468<0.01%US$218No changeNov 2, 2026
Barclays2<0.01%US$1−124Nov 6, 2026
Caitong International Asset Management Co., Ltd2<0.01%US$1No changeOct 29, 2026

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund269K0.61%US$279K+600Jun 30, 2026
Vanguard Extended Market Index Fund148K0.34%US$154K+33,783Jun 30, 2026
Fidelity Extended Market Index Fund99,2470.23%US$108K+36,685May 31, 2026
iShares Micro-Cap ETF49,6600.11%US$51,646+11,895Jun 30, 2026
Fidelity Series Total Market Index Fund27,5480.06%US$30,027+14,920May 31, 2026
Fidelity Total Market Index Fund16,7620.04%US$18,271No changeMay 31, 2026
1290 VT Micro Cap Portfolio2,373<0.01%US$2,468No changeJun 30, 2026
Fidelity Nasdaq Composite Index Fund1,582<0.01%US$1,724No changeMay 31, 2026

Big stakes

HolderStakeSharesDate
Armistice Capital, LLC8.44%3.67MSep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dengyao Jia
Other companies: Lianhe Sowell International Group Ltd (Director · Since at least Mar 18, 2026)
Director · Since at least Sep 22, 2025
Jianwei Li
Other companies: SAIHEAT Limited (CEO / Chairman of The Board · Since at least Apr 28, 2021)
Co-Chief Executive Officer, Director · Jul 14, 2021 – Mar 4, 2022 · Past
Luqi Wen
Other companies: SAIHEAT Limited (CFO and Secretary · Apr 28, 2021 – Apr 28, 2021 · Past)
Chief Financial Officer · Jul 14, 2021 – Jul 14, 2021 · Past
Pei Xu
Other companies: Zhongchao Inc. (Chief Financial Officer, Director · Since at least Mar 18, 2026)
Director · Since at least Sep 29, 2023
Tao Jiang
Other companies: SAIHEAT Limited (Director · Apr 28, 2021 – Apr 28, 2021 · Past)
Director · Jul 14, 2021 – Jul 14, 2021 · Past
Weiguang Yang
Other companies: Zhongchao Inc. (Chief Executive Officer, Director · Since at least Mar 18, 2026)
Co-Chief Executive Officer, Director · Jul 14, 2021 – Jul 14, 2021 · Past
Weston Twigg
Other companies: Tungray Technologies Inc (Director · Since at least Mar 18, 2026)
Director · Jul 14, 2021 – Jul 14, 2021 · Past
Cheng LiuChief Scientific Officer · Since at least Sep 29, 2023
Cynthia PussinenChairperson of the Board · Since Oct 25, 2026
Fan WuDirector · Since at least Sep 29, 2023
All 16 people
PersonSeat
Hong ZhangDirector · Since at least Aug 14, 2024
James LongDirector · Jul 14, 2021 – Jul 14, 2021 · Past
Janelle WuDirector · Since at least Nov 5, 2026
Jiandong XuChief Financial Officer · Since at least Sep 29, 2023
Marsha RobertsDirector · Since at least Sep 29, 2023
Xuejun Janelle WuDirector · Sep 29, 2023 – Sep 29, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Estrella Immunopharma, Inc.